Clinical trials: Oocytes Matured in Vitro
Aneuploidy
Aneuploidy Rates of in Vitro Matured Oocytes
In general, nearly 85% of retrieved oocytes are mature and reproductively useful after the retrieval, whereas the remaining percentage are still at metaphase I or germinal vesicle stage (MI: 4% and GV: 11 %, respectively).
- Trial name
- IVM (NCT03860064)
- Testing
- Non intervention
- Where
- Spain
- Volunteers
- 60 people
- Sponsor
- IVI Barcelona
Oocytes Vitrified at Prophase-I Stage, Oocytes Matured in Vitro
Comparison of Vitrification Effect Before or After In Vitro Maturation
Human oocyte cryopreservation is routinely used for fertility preservation of women who will be exposed to gonadotoxic effect of cancer treatment. After ovarian stimulation, matured oocytes are vitrified.
- Trial name
- NCT03416400
- Testing
- Oocyte vitrification
- Where
- France
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- University Hospital, Clermont-Ferrand
Fertility, Cancer
Methods for Fertility Preservation: Impact of Vitrification on in Vitro Matured Oocytes
During the last decades, there was an improvement of the cancer treatments of the woman and the teenagers. Therefore higher survival rate is described.
- Trial name
- OVOMIV (NCT03680937)
- Testing
- Gavi , Merck® (automated vitrification instrument), Vitrification
- Where
- France
- Volunteers
- 240 people
- Sponsor
- University Hospital, Clermont-Ferrand
Fertility Preservation
Vitrification of Oocytes Matured by CAPA-IVM
It has been reported that the potential of In Vitro matured oocytes might be affected by the vitrification process. In fact, the freezing and thawing procedures routinely used in IVF laboratories, have not yet been adapted to…
- Trial name
- NCT06157619
- Testing
- Oocyte Vitrification /Warming
- Where
- Peru
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Centro de Fertilidad y Reproducción Asistida, Peru